News from oncnursingnews.com

Follow

News from oncnursingnews.com

Stay current with all the latest and breaking news from oncnursingnews.com. Compare headlines and media bias behind news outlets on stories breaking today.

We’ve aggregated 40 of oncnursingnews.com’s headlines and news stories over the past 3 months.

We’ve assigned a media bias rating of unknown to oncnursingnews.com. You can read more about our methodology here.

If you want to know if oncnursingnews.com is credible or reliable, look no further. We rank oncnursingnews.com as unknown factuality. Find out more about our methodology here.

Follow

Stay current with all the latest and breaking news from oncnursingnews.com. Compare headlines and media bias behind news outlets on stories breaking today. We’ve aggregated 40 of oncnursingnews.com’s headlines and news stories over the past 3 months.

We’ve assigned a media bias rating of unknown to oncnursingnews.com. You can read more about our methodology here. If you want to know if oncnursingnews.com is credible or reliable, look no further. We rank oncnursingnews.com as unknown factuality. Find out more about our methodology here.

---

Information about oncnursingnews.com

Where is oncnursingnews.com located?oncnursingnews.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Average Factuality Rating: Unknown

Learn more about Factuality Ratings.

---

Top oncnursingnews.com News

Eli Lilly · United States

Lilly gets traditional FDA approval for Retevmo for thyroid cancer (NYSE:LLY)

100% Right coverage: 1 sources

Eli Lilly (LLY) has received traditional approval for its drug Retevmo for the treatment of medullary thyroid cancer with a RET mutation. Read more here.See the Story

AstraZeneca · United States

FDA Expands Approval of Osimertinib in Lung Cancer

100% Center coverage: 1 sources

The FDA has approved osimertinib (Tagrisso) for locally advanced, unresectable stage III non-small cell lung cancer (NSCLC) following chemoradiotherapy, theSee the Story

United States · United States

Sanofi wins US approval for drug combination to treat multiple myeloma

100% Center coverage: 1 sources

Sanofi won approval for the use of a drug combination with its Sarclisa infusion to treat certain types of newly diagnosed multiple myeloma, where it has previously been used only after standard treatments have failed, the U.S. Food and Drug Administration said on Friday. The French drugmaker, a market leader in anti-inflammatory drugs, has underscored its commitment to oncology drug development even after a once-promising breast cancer drug can…See the Story

---

Latest News Stories

Topics Most Covered by oncnursingnews.com

Cancer

AstraZeneca

Eli Lilly

Breast Cancer

Surveillance

Cancer

AstraZeneca

Eli Lilly

Sources Covering Similar Topics

cancernetwork.com

targetedonc.com

curetoday.com

onclive.com

Pharmacy Times

cancernetwork.com

targetedonc.com

curetoday.com

Suggest a source

Looking for a source we don't already have? Suggest one here.

Breaking News Topics Related to oncnursingnews.com

AstraZeneca

Cancer

United States